Introducing MyTherapy for MS: A Fresh, Open Approach to Supporting People Living with Multiple Sclerosis

With ‘MyTherapy for MS’ we are creating a dedicated and open support offering for thousands of MyTherapy users living with MS. Read what's coming, and how partners from life science and research can join in

Dan Brown May 03, 2021

Dan is a journalism graduate from the UK. He aims to make the complex topic of digital healthcare accessible for both patients and experts, using simple and concise language.

View Dan Brown’s posts

On average, MyTherapy users are active in the app six times a day. These (as we believe outstanding) levels of engagement are a result of countless iterations and the continuous, close cooperation with people living with chronic diseases. This engagement stems from functionality that is designed to help people with any disease, such as managing medications, tracking symptoms, managing appointments, or collaborating with caregivers.

There is a second level of value for users that we have so far never tapped: Serving the support needs that are specific to the disease that a patient is living with. Until today. With ‘MyTherapy for MS’, we are launching our first disease-specific support offering within MyTherapy. On top of MyTherapy’s functionality, ‘MyTherapy for MS’ provides additional content and tools specifically for MS patients – independent of the treatment that they may be on. Read on to learn why we have decided to specifically support people living with multiple sclerosis and how we are working with partners in order to ensure that each patient gets access to the education, inspiration, and tools they need.

MyTherapy for MS: Why?

Multiple sclerosis is also known as the ‘disease with a thousand faces’. For different people, MS can mean wildly different challenges. Most ‘just’ want to live well with their disease. While for some this means to crack along like before the diagnosis, others want to take control of the disease or need to master everyday challenges like fatigue or limited mobility.

What some people in healthcare call a ‘patient journey’, for people living with MS is everything but a journey.

The life science industry operates patient support programs to assist patients in managing their disease. Some of these provide excellent support around a specific treatment. However, they struggle to provide meaningful support for living well with the disease; the broad spectrum of different support needs sums up to a massive unmet need. In addition, many MS patients are reluctant to rely on industry-provided offerings.

We have thousands of MS patients as active users of our MyTherapy platform. We have worked on MS patient support offerings around the globe. We know how big of an unmet need there is. We believe that it is time to break down the silos of traditional patient support programs and to instead join forces for a digital patient support offering of true relevance for almost any MS patient.

An Open Approach

‘MyTherapy for MS’ aims to fulfill the unmet need for support by putting the patient at the center. Users pick the tools, the education, and the inspiration that fit their individual challenges. At the same time, people can use the offering for managing co-morbidities or other health-related needs - a clear departure from today's disease-centric or even product-centric support offerings.

You want to meaningfully educate or support adherence for patients living with MS or other chronic conditions?

See how we can help

Additionally, ‘MyTherapy for MS’ is grounded in an open platform approach. By collaborating with partners from pharma, academia, and digital therapeutics, ‘MyTherapy for MS’ can provide tailored support and education for specific treatments and challenges at a quality and breadth that no single offering can provide. At the same time, ‘MyTherapy for MS’ retains all of MyTherapy’s core functionalities and keeps evolving with monthly updates.

How Partners Can Benefit from ‘MyTherapy for MS’?

Beyond supporting patients, ‘MyTherapy for MS’ opens the door to a range of new partnership opportunities for both the pharmaceutical industry and for research purposes.

Pharma and Biotech

Building a patient support and education app from the ground up is costly and time-consuming, and most offerings are hardly being used. Instead, pharma partners are deploying product-specific support modules within ‘MyTherapy for MS’, thereby immediately benefitting from:

Also, our in-house team of editors are experts in medical writing and behavior change and help partners by translating messages into patient language that clicks and sticks. ‘MyTherapy for MS’ is for pharma companies who want to support their patients where they already are or are looking for sponsoring opportunities for (non-promotional) content available to all patients. Sounds interesting? Don't hesitate to get in touch.

Research and Digital Therapeutics

Throughout the development of MyTherapy, we have partnered with leading medical institutions such as Charité – Universitätsmedizin Berlin and Klinikum rechts der Isar der Technischen Universität München for research purposes.

Research partners can benefit from MyTherapy’s exemplary patient engagement to gain real-world insights into patients’ behavior and attitudes. MyTherapy’s userbase allows researchers to use qualitative data to analyze issues such as medication adherence, while surveys and questionnaires can reach the patient populations that matter to you.

Further, being ISO 13485 certified, we can host medical device grade modules within ‘MyTherapy for MS’, e.g. digital therapeutics (DTx) of software for controlling medical device grade IoT devices.

What's next?

‘MyTherapy for MS’ will be available from summer 2021. If you are interested in taking advantage of the partnering opportunities available using ‘MyTherapy for MS’, please get in touch. And while ‘MyTherapy for MS’ is the first program we are releasing for a specific disease, it will not be the only one, so don't hesitate to reach out if you want to join us in redefining patient support in a condition other than MS.